Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€8.70
03.09.20
-
28.10.20
-0.69%
28.10.20

Could be very worthwhile Investment >20% year
Ceapro Inc

Start price
Target price
Perf. (%)
€0.41
03.09.20
-
03.09.20
-
03.09.20

buy
Grifols S.A.

Start price
Target price
Perf. (%)
€22.77
01.09.20
€30.00
04.11.21
-18.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€32.45
29.08.20
€40.00
04.11.21
-7.18%
05.11.21

Could be worthwhile Investment >10% per year
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.32
26.08.20
€50.00
08.10.20
-2.68%
08.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Teligent Inc.

Start price
Target price
Perf. (%)
€1.05
26.08.20
-
02.09.20
-13.71%
02.09.20

buy
Verastem Inc.

Start price
Target price
Perf. (%)
€13.13
25.08.20
€25.20
04.11.21
120.37%
05.11.21

Could be worthwhile Investment >10% per year
buy
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€145.00
25.08.20
-
04.11.21
-32.43%
05.11.21

Could be very worthwhile Investment >20% year
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
25.08.20
€25.62
03.09.20
-2.45%
03.09.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€207.40
25.08.20
€225.00
21.09.20
-1.23%
21.09.20

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Seres Therapeutics Inc

Start price
Target price
Perf. (%)
€21.00
23.08.20
€12.00
04.11.21
-22.14%
17.06.21

Probably not worthwhile Investment
buy
Veracyte Inc.

Start price
Target price
Perf. (%)
€30.20
23.08.20
€45.00
04.11.21
49.01%
05.11.21

Could be worthwhile Investment >10% per year
Kazia Therapeutics ADR

Start price
Target price
Perf. (%)
€6.50
22.08.20
-
04.11.21
36.15%
17.06.21

Probably not worthwhile Investment
buy
Ceapro Inc

Start price
Target price
Perf. (%)
€0.59
22.08.20
-
03.09.20
-9.40%
03.09.20

iBio Inc.

Start price
Target price
Perf. (%)
€36.75
22.08.20
-
04.11.21
-25.14%
15.07.21

Risky Investment
buy
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€14.64
22.08.20
-
03.09.20
-40.57%
03.09.20

Could be very worthwhile Investment >20% year
buy
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.76
22.08.20
-
07.09.20
-5.48%
07.09.20

Could be very worthwhile Investment >20% year
buy
Photocure ASA Nk-,50

Start price
Target price
Perf. (%)
€8.66
21.08.20
€12.00
04.11.21
41.46%
05.11.21

Could be worthwhile Investment >10% per year
Teligent Inc.

Start price
Target price
Perf. (%)
€1.21
21.08.20
-
26.08.20
-12.86%
26.08.20

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€95.39
20.08.20
€105.50
04.11.21
1.68%
14.06.21

Future proof or reliable business model
Small cyclical dependencies
Known brand
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€7.40
19.08.20
€0.000
04.11.21
-23.65%
05.11.21

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.59
19.08.20
€52.00
24.08.20
0.76%
24.08.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Bayer AG

Start price
Target price
Perf. (%)
€57.13
19.08.20
€70.00
04.11.21
-19.84%
10.11.20

Could be worthwhile Investment >10% per year
Innovative
Very Future proof/growth oriented business model
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.10
18.08.20
-
04.11.21
-12.10%
11.11.20

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
iBio Inc.

Start price
Target price
Perf. (%)
€54.00
15.08.20
€17.50
04.11.21
-22.69%
20.02.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products